Clinical trial
Impact of Donor-recipient ABO Matching on Patients' Outcome After Peripheral Blood Stem Cell Haploidentical Stem Cell Transplantation
NCT05103995 is registered in ClinicalTrials.gov with First Affiliated Hospital of Zhejiang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Donor-recipient ABO Matching on Patients' Outcome After Peripheral Blood Stem Cell Haploidentical Stem Cell Transplantation
- Lead sponsor
- First Affiliated Hospital of Zhejiang University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2013
- Completion date
- October 1, 2021
- Enrollment
- 510 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
haploidentical stem cell transplantation, hematological malignancies